Contineum Therapeutics, Inc. (CTNM)
NASDAQ · Healthcare
Contineum Therapeutics, Inc. Income Statement 2023–2024
| Dec 2024 | Dec 2023 | |
|---|---|---|
| Revenues | ||
| Revenue | 0 | 50.0M |
| Gross Profit | — | — |
| Profitability | ||
| Operating Income | -50.9M | 16.1M |
| EBITDA | -50.6M | 16.3M |
| Net Income | -42.3M | 22.7M |
| Per Share Data | ||
| EPS (diluted) | — | — |
| Shares Outstanding (dil.) | 19M | 3M |
Contineum Therapeutics, Inc. Income Statement — FAQ
Contineum Therapeutics, Inc. (CTNM) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTNM's income statement history?
The chart and table above show Contineum Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.